PT - JOURNAL ARTICLE AU - Klein, Eran AU - Bourdette, Dennis TI - Postmarketing adverse drug reactions AID - 10.1212/CPJ.0b013e3182a1b9f0 DP - 2013 Aug 01 TA - Neurology: Clinical Practice PG - 288--294 VI - 3 IP - 4 4099 - http://cp.neurology.org/content/3/4/288.short 4100 - http://cp.neurology.org/content/3/4/288.full AB - Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.